Crossref
Why tumors outsmart immunotherapy: the hidden role of intratumoral heterogeneity
Nowotwory. Journal of Oncology · 30.10.2026 · 76 (5) · 298-306
DOI: 10.5603/njo.112266 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nowotwory. Journal of Oncology, online erschienen am 30.10.2026. Verfasst von Ahmed Sohaib und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Sohaib, A., Hosny, S., Salah, M., & Shalaby, M. (2026). Why tumors outsmart immunotherapy: the hidden role of intratumoral heterogeneity. Nowotwory. Journal of Oncology, 76(5), 298-306. https://doi.org/10.5603/njo.112266
Vancouver
Sohaib A, Hosny S, Salah M, Shalaby M. Why tumors outsmart immunotherapy: the hidden role of intratumoral heterogeneity. Nowotwory. Journal of Oncology. 2026;76(5):298-306. doi:10.5603/njo.112266
BibTeX
@article{Sohaib2026,
author = {Sohaib, Ahmed and Hosny, Samar and Salah, Manar and Shalaby, Mohamed},
title = {Why tumors outsmart immunotherapy: the hidden role of intratumoral heterogeneity},
journal = {Nowotwory. Journal of Oncology},
year = {2026},
volume = {76},
number = {5},
pages = {298--306},
doi = {10.5603/njo.112266}
}
EUVIMED